Heparin use in acute ischaemic stroke: Does evidence change practice?

QJM: An International Journal of Medicine

Volumn 98, Issue 2, 2005, Pages 147-152

  Benatar, M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CERTOPARIN; DALTEPARIN; DANAPAROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; EXPERIENCE; HUMAN; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; NEUROLOGY; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 14044266951     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hci014     Document Type: Article

References (14)

1. Anderson DC. How twin cities neurologists treat ischemic stroke: policies and trends. Arch Neurol 1993; 50: 1098-103.
2. Al-Sadat A, Subulli M, Chaturvedi S. Use of intravenous heparin by North American Neurologists. Do the data matter? Stroke 2002; 33:1574-77.
3. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of asprin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-81.
4. Duke R, Bloch R, Turpie A. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Intern Med 1986; 105:825-8.
5. Caplan LR. Resolved: Heparin may be useful in selected patients with brain ischemia. Stroke 2003; 34:230-1.
6. Sandercock P. Full heparin anticoagulation should not be used in acute ischemic stroke. Stroke 2003; 34:231-2.
7. Kay R. Wong K, Yu Y, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995; 333:1588-93.
8. Hommel M. Fraxiparine in ischemic stroke study (FISSbis). Cerebrovasc Dis 1998; 4(Suppl.):19.
9. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaproid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279 1265-72.
10. Chamorro A. Heparin in acute ischemic stroke: the case for a new clinical trial. Cerebrovasc Dis 1999; 9(Supplement 3) 16-23.
11. Berge E, Abdelnoor M, Nakstad P, Sandset P. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Lancet 2000; 355.
12. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983; 14:668-76.
13. Bath PM, Lindsenstrom E, Gudrun B, et al., for the TAIST Investigators. Tinzaparin in Acute Ischaemic Stroke Trial (TAIST): a randomized asprin-controlled trial. Lancet 2001; 358 702-10.
14. Diener HC, Ringelstein EB, von Kummer R, et al. for the Therapy of Patients with Acute Stroke (TOPAS) Investigators. Treatment of acute ischemic stroke with the low-molecular weight heparin certoparin. Results of the TOPAS trial. Stroke 2001; 32:22-9.